Bank of America
CLYM

Bank of America’s Climb Bio CLYM Stock Holding History

Bank of America’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Sell
25,664
-27,257
-52% -$282K ﹤0.01% 5154
2026
Q1 		$363K Buy
52,921
+47,858
+945% +$276K ﹤0.01% 5061
2025
Q4 		$20.3K Sell
5,063
-690
-12% -$1.66K ﹤0.01% 6049
2025
Q3 		$11.6K Sell
5,753
-1,874
-25% -$3.48K ﹤0.01% 7174
2025
Q2 		$9.46K Sell
7,627
-29,660
-80% -$36.9K ﹤0.01% 7205
2025
Q1 		$45.5K Sell
37,287
-996,405
-96% -$1.62M ﹤0.01% 6776
2024
Q4 		$1.86M Buy
1,033,692
+1,016,323
+5,851% +$3.68M ﹤0.01% 4507
2024
Q3 		$88.4K Buy
17,369
+8,122
+88% +$57.5K ﹤0.01% 6375
2024
Q2 		$65.7K Buy
+9,247
New +$61.5K ﹤0.01% 6428
2024
Q1 		– Sell
-3
Closed -$8 – 8259
2023
Q4 		$8 Sell
3
-1,387
-100% -$3.61K ﹤0.01% 7816
2023
Q3 		$3.66K Buy
1,390
+471
+51% +$1.28K ﹤0.01% 7059
2023
Q2 		$2.57K Buy
919
+224
+32% +$680 ﹤0.01% 7107
2023
Q1 		$2.02K Sell
695
-4
-0.6% -$14 ﹤0.01% 7216
2022
Q4 		$2.56K Buy
699
+3
+0.4% +$9 ﹤0.01% 7185
2022
Q3 		$2K Sell
696
-2,688
-79% -$8.58K ﹤0.01% 7596
2022
Q2 		$10K Buy
3,384
+1,845
+120% +$8.73K ﹤0.01% 7400
2022
Q1 		$13K Sell
1,539
-2,760
-64% -$25.7K ﹤0.01% 7668
2021
Q4 		$45K Buy
4,299
+3,685
+600% +$54.9K ﹤0.01% 7267
2021
Q3 		$11K Buy
+614
New +$12.7K ﹤0.01% 7557

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America's CLYM Position: Q2 2026 in Review

Bank of America reduced its Climb Bio (CLYM) stake by 52% in Q2 2026, selling an estimated $282K and leaving 25,664 shares worth $335K. The position accounts for ﹤0.01% of the portfolio, ranked #5154.

Bank of America first reported a position in CLYM in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.86M in Q4 2024. 108 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Bank of America held 25,664 shares of Climb Bio worth $335K as of Q2 2026.
  • Bank of America sold 27,257 Climb Bio shares in Q2 2026, an estimated $282K.
  • Climb Bio made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #5154 holding.
  • Bank of America first reported a position in Climb Bio in Q3 2021 and has held it in 19 quarters since.
  • Bank of America's Climb Bio position peaked at $1.86M in Q4 2024.
  • 108 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.